Financhill
Back

Intellia Therapeutics Quote, Financials, Valuation and Earnings

Intellia Therapeutics Price Quote

$14.58
-0.41 (-2.74%)
(Updated: October 30, 2024 at 2:25 PM ET)

Intellia Therapeutics Key Stats

Sell
16
Intellia Therapeutics (NTLA) is a Sell

Day range:
$14.70 - $16.26
52-week range:
$14.70 - $34.87
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
30.50
P/B ratio:
1.57%

Volume:
4.3M
Avg. volume:
2.3M
1-year change:
-35.28%
Market cap:
$1.5B
Revenue:
$36.3M
EPS:
$-5.48

How Much Does Intellia Therapeutics Make?

Is Intellia Therapeutics Growing As A Company?

  • What Is Intellia Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.49%
  • What Is Intellia Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Intellia Therapeutics Stock Price Performance

What Is Intellia Therapeutics 52-Week High & Low?

Intellia Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Intellia Therapeutics?

Is Intellia Therapeutics Cash Flow Positive?

  • What Is NTLA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$373.3M
  • What Is Intellia Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $226.8M
  • What Is Intellia Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $107.2M

Intellia Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    NTLA return on invested capital is -48.93%
  • What Is Intellia Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -40.26%
  • What Is NTLA Return On Equity?
    ROE is a measure of profitability and is -48.93%

Intellia Therapeutics Earnings Date & Stock Price

Intellia Therapeutics Competitors

Intellia Therapeutics Dividend Yield

Intellia Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -27.02%
Revenue: -48.82% -63.69%

Analyst Recommendations

Buy Recommendations: 18
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 64.33
Upside from Last Price: 329.18%

Major Shareholders

  • How many NTLA shares are owned by institutional investors?
    129.1M NTLA shares are owned by institutional investors
  • How many NTLA shares are owned by insiders?
    3M NTLA shares are owned by insiders